Immunologic Outcomes of Antiretroviral Therapy Among HIV-infected Nigerian Children and Its Association with Early Infant Feeding and Nutritional Status at Treatment Initiation

Pediatric Infectious Disease Journal

Volumn 32, Issue 7, 2013, Pages e291-e297

  Omoni, Adetayo O ^a   Christian, Parul S ^a   Sadoh, Wilson E ^a   Okechukwu, Adaora ^a   Olateju, Eyinade ^a   Omoigberale, Austin ^a   Blattner, William ^a   Charurat, Man E ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Antiretroviral therapy; Early infant feeding; HIV infected children; Immunologic outcomes; Nutritional status

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ANTIVIRAL THERAPY; ARTICLE; ARTIFICIAL MILK; BODY HEIGHT; BODY WEIGHT; BREAST FEEDING; CD4 LYMPHOCYTE COUNT; CHILD; CONTROLLED STUDY; FEEDING BEHAVIOR; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFANT FEEDING; MAJOR CLINICAL STUDY; MALE; NIGERIA; NUTRITIONAL STATUS; PRESCHOOL CHILD; PRIORITY JOURNAL; TREATMENT DURATION; UNDERWEIGHT;

ADULT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; MALE; NIGERIA; NUTRITIONAL STATUS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84883212020     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31828b2a2f     Document Type: Article

References (51)

1. Resino S, Galán I, Pérez A, et al. HIV-infected children with moderate/severe immune-suppression: changes in the immune system after highly active antiretroviral therapy. Clin Exp Immunol. 2004;137:570-577
2. Grant A. Clinical features of HIV disease in developing countries. Lepr Rev. 2002;73:197-205
3. World Health Organization. WHO Pediatric HIV Guidelines 2006. Antiretroviral therapy of HIV infection in infants and children in resource-limited settings: towards universal access
4. World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: Recommendations for a public health approach. 2006 Revision. Available at: http://www.who.int/hiv/pub/guidelines/artadultguidelines.pdf
5. Ghaffari G, Passalacqua DJ, Caicedo JL, et al. Two-year clinical and immune outcomes in human immunodeficiency virus-infected children who reconstitute CD4 T cells without control of viral replication after combination antiretroviral therapy. Pediatrics. 2004;114:604-611
6. UNAIDS. UNAIDS Report on the Global AIDS epidemic 2010. Available at: http://www.unaids.org/documents/20101123_GlobalReport_em.pdf. Accessed June 22, 2011.
7. De Baets AJ, Bulterys M, Abrams EJ, et al. Care and treatment of HIV-infected children in Africa: issues and challenges at the district hospital level. Pediatr Infect Dis J. 2007;26:163-173
8. De Baets AJ, Ramet J, Msellati P, et al. The unique features of pediatric HIV-1 in sub-Saharan Africa. Curr HIV Res. 2008;6:351-362
9. Fassinou P, Elenga N, Rouet F, et al. Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Côte d’Ivoire. AIDS. 2004;18:1905-1913
10. Rouet F, Fassinou P, Inwoley A, et al.ANRS 1244/1278 Programme Enfants Yopougon. Long-term survival and immuno-virological response of African HIV-1-infected children to highly active antiretroviral therapy regimens. AIDS. 2006;20:2315-2319
11. Eley B, Davies MA, Apolles P, et al. Antiretroviral treatment for children. S Afr Med J. 2006;96(9 Pt 2):988-993
12. Song R, Jelagat J, Dzombo D, et al. Efficacy of highly active antiretroviral therapy in HIV-1 infected children in Kenya. Pediatrics. 2007;120:e856-e861
13. Wamalwa DC, Farquhar C, Obimbo EM, et al. Early response to highly active antiretroviral therapy in HIV-1-infected Kenyan children. J Acquir Immune Defic Syndr. 2007;45:311-317
14. Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, et al. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA. 2007;298:1888-1899
15. Reddi A, Leeper SC, Grobler AC, et al. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa. BMC Pediatr. 2007;7:13
16. Jaspan HB, Berrisford AE, Boulle AM. Two-year outcomes of children on non-nucleoside reverse transcriptase inhibitor and protease inhibitor regimens in a South African pediatric antiretroviral program. Pediatr Infect Dis J. 2008;27:993-998
17. Adjé-Touré C, Hanson DL, Talla-Nzussouo N, et al. Virologic and immunologic response to antiretroviral therapy and predictors of HIV type 1 drug resistance in children receiving treatment in Abidjan, Côte d’Ivoire. AIDS Res Hum Retroviruses. 2008;24:911-917
18. Gibb DM, Newberry A, Klein N, et al. Immune repopulation after HAART in previously untreated HIV-1-infected children. Paediatric European Network for Treatment of AIDS (PENTA) Steering Committee. Lancet. 2000;355:1331-1332
19. Resino S, Resino R, Micheloud D, et al.Spanish Group of Paediatric HIV Infection. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up. Clin Infect Dis. 2006;42:862-869
20. Doerholt K, Duong T, Tookey P, et al.Collaborative HIV Paediatric Study. Outcomes for human immunodeficiency virus-1-infected infants in the United kingdom and Republic of Ireland in the era of effective antiretroviral therapy. Pediatr Infect Dis J. 2006;25:420-426
21. Chiappini E, Galli L, Tovo PA, et al.Italian Register for HIV Infection in Children. Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection. AIDS. 2006;20:207-215
22. Coutsoudis A. Infant feeding dilemmas created by HIV: South African experiences. J Nutr. 2005;135:956-959
23. World Health Organization. Guidelines on HIV and Infant Feeding 2010. Principles and Recommendations for Infant Feeding in the Context of HIV and a Summary of Evidence. 2010 Geneva, Switzerland World Health Organization
24. Violari A, Cotton MF, Gibb DM, et al.CHER Study Team. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med. 2008;359:2233-2244
25. World. Health Organization. WHO Multicentre Growth Reference Study Group (2006). WHO Child Growth Standards: Length/Height-for-Age, Weight-for-Age, Weight-for-Length, Weight-for-Height and Body Mass Index-for-Age. Methods and Development. 2006 Geneva, Switzerland World Health Organization:312
26. World Health Organization. HIV and Infant Feeding: New Evidence and Programmatic Experience: Report of a Technical Consultation Held on Behalf of the Inter-agency Task Team (IATT) on Prevention of HIV Infections in Pregnant Women, Mothers and Their Infants. 2007 Geneva, Switzerland World Health Organization
27. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics. 1982;38:963-974
28. Ciaranello AL, Chang Y, Margulis AV, et al. Effectiveness of pediatric antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis. Clin Infect Dis. 2009;49:1915-1927
29. O’Brien DP, Sauvageot D, Olson D, et al.Médecins Sans Frontières. Treatment outcomes stratified by baseline immunological status among young children receiving nonnucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in resource-limited settings. Clin Infect Dis. 2007;44:1245-1248
30. Hainaut M, Ducarme M, Schandene L, et al. Age-related immune reconstitution during highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children. Pediatr Infect Dis J. 2003;22:62-69
31. Walker AS, Doerholt K, Sharland M, et al.Collaborative HIV Paediatric Study (CHIPS) Steering Committee. Response to highly active antiretroviral therapy varies with age: the UK and Ireland Collaborative HIV Paediatric Study. AIDS. 2004;18:1915-1924
32. Franco JM, León-Leal JA, Leal M, et al. CD4+ and CD8+ T lymphocyte regeneration after anti-retroviral therapy in HIV-1-infected children and adult patients. Clin Exp Immunol. 2000;119:493-498
33. Soh CH, Oleske JM, Brady MT, et al.Pediatric AIDS Clinical Trials Group. Long-term effects of protease-inhibitor-based combination therapy on CD4 T-cell recovery in HIV-1-infected children and adolescents. Lancet. 2003;362:2045-2051
34. Berhane R, Bagenda D, Marum L, et al. Growth failure as a prognostic indicator of mortality in pediatric HIV infection. Pediatrics. 1997;100:E7
35. Fiore P, Donelli E, Boni S, et al. Nutritional status changes in HIV-infected children receiving combined antiretroviral therapy including protease inhibitors. Int J Antimicrob Agents. 2000;16:365-369
36. Semba RD, Tang AM. Micronutrients and the pathogenesis of human immunodeficiency virus infection. Br J Nutr. 1999;81:181-189
37. Aurpibul L, Puthanakit T, Taecharoenkul S, et al. Reversal of growth failure in HIV-infected Thai children treated with non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy. AIDS Patient Care STDS. 2009;23:1067-1071
38. Kabue MM, Kekitiinwa A, Maganda A, et al. Growth in HIV-infected children receiving antiretroviral therapy at a pediatric infectious diseases clinic in Uganda. AIDS Patient Care STDS. 2008;22:245-251
39. Kekitiinwa A, Lee KJ, Walker AS, et al.Collaborative HIV Paediatric Study (CHIPS) Steering Committe; Mulago Cohort Team. Differences in factors associated with initial growth, CD4, and viral load responses to ART in HIV-infected children in Kampala, Uganda, and the United Kingdom/Ireland. J Acquir Immune Defic Syndr. 2008;49:384-392
40. Naidoo R, Rennert W, Lung A, et al. The influence of nutritional status on the response to HAART in HIV-infected children in South Africa. Pediatr Infect Dis J. 2010;29:511-513
41. Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, et al. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA. 2007;298:1888-1899
42. Bong CN, Yu JK, Chiang HC, et al. Risk factors for early mortality in children on adult fixed-dose combination antiretroviral treatment in a central hospital in Malawi. AIDS. 2007;21:1805-1810
43. Rajasekaran S, Jeyaseelan L, Ravichandran N, et al. Efficacy of antiretroviral therapy program in children in India: prognostic factors and survival analysis. J Trop Pediatr. 2009;55:225-232
44. Taye B, Shiferaw S, Enquselassie F. The impact of malnutrition in survival of HIV infected children after initiation of antiretroviral treatment (ART). Ethiop Med J. 2010;48:1-10
45. Hughes SM, Amadi B, Mwiya M, et al. CD4 counts decline despite nutritional recovery in HIV-infected Zambian children with severe malnutrition. Pediatrics. 2009;123:e347-e351
46. Chandra RK. Nutritional regulation of immunity and risk of illness. Indian J Pediatr. 1989;56:607-611
47. Baum MK, Shor-Posner G, Lu Y, et al. Micronutrients and HIV-1 disease progression. AIDS. 1995;9:1051-1056
48. Tang AM, Graham NM, Chandra RK, et al. Low serum vitamin B-12 concentrations are associated with faster human immunodeficiency virus type 1 (HIV-1) disease progression. J Nutr. 1997;127:345-351
49. Bogden JD, Kemp FW, Han S, et al. Status of selected nutrients and progression of human immunodeficiency virus type 1 infection. Am J Clin Nutr. 2000;72:809-815
50. Kaiser JD, Campa AM, Ondercin JP, et al. Micronutrient supplementation increases CD4 count in HIV-infected individuals on highly active antiretroviral therapy: a prospective, double-blinded, placebo-controlled trial. J Acquir Immune Defic Syndr. 2006;42:523-528
51. Palumbo P, Lindsey JC, Hughes MD, et al. Antiretroviral treatment for children with peripartum nevirapine exposure. N Engl J Med. 2010;363:1510-1520